ArticleACS pharmacology & translational science2026
Influence of Lipid Composition on Nonspecific Interactions of Serotonin with Model Membranes.
Article in ACS pharmacology & translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serotonin is a monoamine neurotransmitter, which plays an important role in the development and functioning of the central nervous system. Recent biophysical studies reveal that nonspecific interactions between serotonin and lipid membranes significantly alter lipid bilayer properties, impacting synaptic function and plasticity. To better understand these critical interactions and their broader implications for neural function and pharmacology, we investigated the interactions of serotonin (at concentrations ranging from 1 to 40 mM) with model membranes prepared as droplet interface bilayers, liposomes, and supported bilayers. These membrane systems comprised single, binary, and ternary lipid mixtures, including pure DOPC, DOPC/DOPS (10:1 mol ratio), and DOPC/Sphingomyelin/Cholesterol (1:1:0.2 mol ratio). Our analysis employing various experimental techniques shows that the interaction of serotonin with lipid membranes of diverse compositions has overall nonspecific effects in (1) influencing the barrier properties of the lipid membrane, as demonstrated by increased water permeability compared to the control; (2) modifying the phase transition behavior, evidenced by decrease in the main phase transition temperature and reduction of the transition enthalpy; (3) perturbing the conformational ordering of lipid membranes, as indicated by the increase in specific Raman intensity ratio; and (4) reducing bilayer tension with increasing serotonin concentrations. Overall, membrane modifications increase with rising serotonin concentrations, plateauing at higher levels. Sensitivity to serotonin varies by lipid composition in the order: DOPC/DOPS ≈ DOPC/Sphingomyelin/Cholesterol > DOPC. Our experimental findings reveal that serotonin significantly alters membrane properties, particularly affecting neuronal membrane composition and lipid rafts, which are critical for membrane protein organization and signaling. These findings suggest that serotonergic drugs and pathological fluctuations in serotonin may influence signaling not only through classical receptor-mediated pathways, but also by altering the lipid-protein landscape of the membrane, with potential implications for drug efficacy, off-target effects, and the development of therapies that target membrane composition in serotonin-related disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.